Want to see AGIO full AI Analyst Report?
Agios Pharma (AGIO) Income Statement
Agios Pharma Income Statement
Last quarter (Q2 2026), Agios Pharma's total revenue was $44.74M, an increase of 259.25% from the same quarter last year. In Q2, Agios Pharma's net income was $-100.70M. See Agios Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 54.03M | $ 36.50M | $ 26.82M | $ 14.24M | $ 0.00 | |
| $ 42.51M | $ 32.33M | $ 17.32M | $ 12.54M | $ -18.78M | |
| $ 514.64M | $ 458.07M | $ 408.81M | $ 401.58M | $ 359.64M | |
| Depreciation and Amortization | $ 5.18M | $ 5.65M | $ 6.62M | $ 8.56M | $ 9.24M |
| $ -408.62M | $ 723.62M | $ -345.46M | $ -223.24M | $ -347.27M | |
| $ -472.13M | $ -425.74M | $ -391.49M | $ -389.05M | $ -378.42M | |
| $ 58.34M | $ 1.14B | $ 39.40M | $ 157.25M | $ 21.91M | |
| $ -413.80M | $ 717.97M | $ -352.09M | $ -231.80M | $ -356.51M | |
| $ -412.78M | $ 673.73M | $ -352.09M | $ -231.80M | $ 1.60B | |
| Per Share Metrics | |||||
| Basic EPS | $ -7.12 | $ 11.86 | $ -6.33 | $ -4.23 | $ -6.36 |
| Diluted EPS | $ -7.12 | $ 11.64 | $ -6.33 | $ -4.23 | $ -6.36 |
| Weighted Average Shares Outstanding | 57.97M | 56.81M | 55.65M | 54.79M | 60.45M |
| Weighted Average Shares Outstanding (Diluted) | 57.97M | 57.89M | 55.65M | 54.79M | 60.45M |
Currency in USD
